Lansoprazole vs Nivolumab
Lansoprazole vs Nivolumab: Overview
This comparison examines the pharmacological differences between Lansoprazole and Nivolumab.
Mechanism of Action
Lansoprazole: Proton pump inhibitor.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Lansoprazole β 1.5 hours; Nivolumab β 27 days.
Chemical Properties
Molecular Formula: Lansoprazole β C16H14F3N3O2S.
Molecular Weight: Lansoprazole β 369.3620 g/mol.
Type: Lansoprazole β Small molecule; Nivolumab β Antibody.